Teva Gets Investment From Royalty On Olanzapine LAI

Follows Successful Launch Of Uzedy LAI Risperidone In The US Earlier This Year

 
• By David Wallace
  
Dollar sign wearing crown with gold background
Teva has garnered investment from Royalty in olanzapine LAI • Source: Shutterstock

More from Deals

More from Business